Piper Sandler Starts Solid Biosciences (SLDB) at Overweight

Piper Sandler analyst Biren Amin initiates coverage on Solid Biosciences (NASDAQ: SLDB) with a Overweight rating and a price target of $20.00.

For an analyst ratings summary and ratings history on Solid Biosciences click here. For more ratings news on Solid Biosciences click here.

Shares of Solid Biosciences closed at $7.64 yesterday.

You May Also Be Interested In

• ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
• Jefferies Starts Aehr Test Systems (AEHR) at Buy
• Solid Biosciences (SLDB) Reiterated at Market Outperform by Citizens on Continued Execution